Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Schizophrenia
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Schizophrenia
    Lower Childhood IQ Associated With Higher Risk of Adult Mental Disorders - (DGNews)
    TopAbstracts in Schizophrenia 11/27/2008 - (DGNews)
    TopAbstracts in Schizophrenia 11/13/2008 - (DGNews)
    Safety and Tolerability of Quetiapine in Children and Adolescents With Bipolar I Disorder and Adolescents With Schizophrenia: Presented at AACAP - (DGDispatch)
    TopAbstracts in Schizophrenia 10/30/2008 - (DGNews)

    News archive

     Recent webcasts/CME - Schizophrenia

    Webcasts/CME archive

     Recent cases - Schizophrenia
      Massive Pulmonary Emboli Associated with Olanzapine
      Presentation and Course of Brain Metastases from Breast Cancer in a Paranoid-Schizophrenic Patient: A Case Report
      Diabetic Control and Atypical Antipsychotics: A Case Report
      A Familial Concurrence of Schizophrenia and Gaucher's Disease
      Necrotising Colitis Related to Clozapine? A Rare but Life Threatening Side Effect

      Cases archive
        




      my personal edition > schizophrenia > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Anticholinergic Drugs May Influence Verbal Memory In Patients With Schizophrenia

      A DGReview of :"Medications and verbal memory impairment in schizophrenia: the role of anticholinergic drugs"
      Psychological Medicine

      03/09/2004
      By Emma Hitt, PhD


      Anticholinergic drugs may impede on semantic organisation at encoding, contributing to the verbal memory deficit observed in patients with schizophrenia , new research suggests.

      Previous studies have shown an association between anticholinergicity and verbal memory impairment. Impairment in visual memory with anticholinergic drugs has also been reported; however, the components of memory specifically affected by these drugs have not been clearly established.

      Gildas Brebion, MD, with the Institute of Psychiatry, Department of Psychological Medicine, in London, United Kingdom, and colleagues assessed the effect of 3 types of medication on verbal memory impairments in schizophrenia.

      Forty-eight patients with schizophrenia and 40 healthy control subjects underwent a battery of verbal memory tasks, including free recall, recognition and short-term memory span. Schizophrenic patients were all taking antipsychotic medication, 24 were taking anticholinergic drugs (benztropine), and 30 were taking benzodiazepines. In addition, 39 patients had depressive symptoms.

      The type of antipsychotic medication used did not contribute to memory deficits, the researchers report. In addition, benzodiazepines had minimal effects. However, anticholinergic medication was a predictor of memory impairment, especially with regard to semantic organization.

      Complementary analyses revealed that patients taking any type of drug with anticholinergic activity (benztropine and/or antipsychotic agents) were significantly impaired relative to the other patients on measures reflecting free recall efficiency and semantic organization.

      "These findings have clinical implications as they point out a potential drawback of using antipsychotic medication dosages that may induce extrapyramidal side effects," Dr. Brebion and colleagues conclude.

      According to the researchers, use of conventional or atypical neuroleptic drugs may be less important in terms of memory efficiency than their potential anticholinergic properties.

      "Clinicians should consider anticholinergic potency of antipsychotic medication when administering pharmacological treatment," they suggest.

      Psychol Med 2004;34:369-374. "Medications and verbal memory impairment in schizophrenia: the role of anticholinergic drugs"

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send